CUSIP: 02290A102
What is CUSIP 02290A102?
CUSIP 02290A102 identifies AMAM - AMBRX BIOPHARMA INC - SPONSORED ADS in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 02290A102:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2024 Q1 | 0 | $0 | -$828,611 | 0 | |
| 2023 Q4 | 58,189 | $828,611 | -$567,068,034 | $14.24 | 1 |
| 2023 Q3 | 49,416,240 | $568,286,721 | -$2,289,975 | $11.50 | 44 |
| 2023 Q2 | 47,920,404 | $788,769,883 | +$181,589,570 | $16.46 | 42 |
| 2023 Q1 | 37,072,853 | $330,687,308 | +$178,415,630 | $8.92 | 30 |
| 2022 Q4 | 17,921,109 | $40,682,047 | +$8,108,215 | $2.27 | 16 |
| 2022 Q3 | 16,655,682 | $17,988,000 | -$788,925 | $1.08 | 14 |
| 2022 Q2 | 17,117,833 | $45,361,349 | -$54,747 | $2.65 | 13 |
| 2022 Q1 | 17,136,849 | $70,603,400 | +$1,196,449 | $4.12 | 14 |
| 2021 Q4 | 16,830,567 | $151,980,000 | +$39,828,647 | $9.03 | 16 |
| 2021 Q3 | 12,412,289 | $165,338,000 | -$29,135,980 | $13.50 | 14 |
| 2021 Q2 | 13,929,686 | $266,216,000 | +$266,215,999 | $19.60 | 20 |